Literature DB >> 16875860

Reduction of organ motion effects in IMRT and conformal 3D radiation delivery by using gating and tracking techniques.

P Giraud1, E Yorke, S Jiang, L Simon, K Rosenzweig, G Mageras.   

Abstract

Respiration-gated radiotherapy offers a significant potential for improvement in the irradiation of tumour sites affected by respiratory motion such as lung, breast and liver tumours. An increased conformality of irradiation fields leading to decreased complications rates of organs at risk (lung, heart) is expected. Four main strategies are used to reduce respiratory motion effects: integration of respiratory movements into treatment planning, breath-hold techniques, respiratory gating techniques, and tracking techniques. Measurements of respiratory movements can be performed either in a representative sample of the general population, or directly on the patient before irradiation. The measured amplitude could be applied to a geometrical margin or integrated into dosimetry. However, these strategies remain limited for very mobile tumours, in which this approach results in larger irradiated volumes. Reduction of breathing motion can be achieved by using either breath-hold techniques or respiration synchronized gating techniques. Breath-hold can be achieved with active techniques, in which a valve temporarily blocks airflow of the patient, or passive techniques, in which the patient voluntarily breath-holds. Synchronized gating techniques use external devices to predict the phase of the respiration cycle while the patient breaths freely. Another category is tumour tracking, which consists of two major aspects: real-time localization of, and real-time beam adaptation to, a constantly moving tumour. These techniques are presently being investigated in several medical centres worldwide. Although promising, the first results obtained in lung and liver cancer patients require confirmation. This paper describes the most frequently used gating and tracking techniques and the main published clinical reports.

Entities:  

Mesh:

Year:  2006        PMID: 16875860     DOI: 10.1016/j.canrad.2006.05.009

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  21 in total

1.  Radiation oncology: a primer for medical students.

Authors:  Abigail T Berman; John P Plastaras; Neha Vapiwala
Journal:  J Cancer Educ       Date:  2013-09       Impact factor: 2.037

Review 2.  Cardiac side effects of conventional and particle radiotherapy in cancer patients.

Authors:  A Wittig; R Engenhart-Cabillic
Journal:  Herz       Date:  2011-06       Impact factor: 1.443

Review 3.  Motion management in gastrointestinal cancers.

Authors:  Hassan Abbas; Bryan Chang; Zhe Jay Chen
Journal:  J Gastrointest Oncol       Date:  2014-06

4.  Are fiducial markers useful surrogates when using respiratory gating to reduce motion of gastroesophageal junction tumors?

Authors:  Fenghong Liu; Shu Ng; Florence Huguet; Ellen D Yorke; Gikas S Mageras; Karyn A Goodman
Journal:  Acta Oncol       Date:  2016-05-06       Impact factor: 4.089

5.  Daily CT guidance improves target coverage during definitive radiation therapy for gastric MALT lymphoma.

Authors:  He Wang; Sarah A Milgrom; Bouthaina S Dabaja; Grace L Smith; Mary Martel; Chelsea C Pinnix
Journal:  Pract Radiat Oncol       Date:  2017-03-06

6.  Real-time marker-less tumor tracking with TOF PET:in silicofeasibility study.

Authors:  Xinyi Cheng; Dongxu Yang; Yuncheng Zhong; Yiping Shao
Journal:  Phys Med Biol       Date:  2022-05-26       Impact factor: 4.174

7.  Couch and multileaf collimator tracking: A clinical feasibility study for pancreas and liver treatment.

Authors:  Lei Zhang; Thomas LoSasso; Pengpeng Zhang; Margie Hunt; Gig Mageras; Grace Tang
Journal:  Med Phys       Date:  2020-09-11       Impact factor: 4.071

8.  Techniques of interventional tumor therapy.

Authors:  Andreas H Mahnken; Philipp Bruners; Rolf W Günther
Journal:  Dtsch Arztebl Int       Date:  2008-09-19       Impact factor: 5.594

Review 9.  Advanced radiation techniques for locally advanced non-small cell lung cancer: intensity-modulated radiation therapy and proton therapy.

Authors:  Nikhil Yegya-Raman; Wei Zou; Ke Nie; Jyoti Malhotra; Salma K Jabbour
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

10.  Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study.

Authors:  Coen W Hurkmans; Johan P Cuijpers; Frank J Lagerwaard; Joachim Widder; Uulke A van der Heide; Danny Schuring; Suresh Senan
Journal:  Radiat Oncol       Date:  2009-01-12       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.